Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials

Abstract

In the past few decades, the development of medicine at the nanoscale has been applied to oral and parenteral dosage forms in a wide range of therapeutic areas to enhance drug delivery and reduce toxicity. An obvious response to these benefits is reflected in higher market shares of complex drug products containing nanomaterials than that of conventional… (More)
DOI: 10.1208/s12248-017-0044-1

Topics

8 Figures and Tables

Cite this paper

@article{Zheng2017ScientificAR, title={Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials}, author={Nan Zheng and Dajun Sun and Peng Zou and Wenlei Jiang}, journal={The AAPS Journal}, year={2017}, volume={19}, pages={619-631} }